Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pointner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Tierarztliche Praxis|January 1, 1986
[Clitoral massage as a supporting measure in manipulation of the bovine uterus]J Pointner
Der Urologe. Ausg. A|May 1, 1996
[Laparoscopic spermatic vein ligation]J Pointner, G Janetschek, A Reissigl, et al.
The Prostate|March 1, 1997
Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levelsA Reissigl, H Klocker, J Pointner, et al.
The Prostate|February 1, 1997
Frequency and clinical significance of transition zone cancer in prostate cancer screeningA Reissigl, J Pointner, H Strasser, et al.
Urology|November 1, 1995
Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening studyA Reissigl, J Pointner, W Horninger, et al.
The Prostate|January 1, 1997
PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donorsA Reissigl, J Pointner, W Horninger, et al.
Urology|December 1, 1996
Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screeningA Reissigl, H Klocker, J Pointner, et al.
Head & Neck|August 8, 2024
A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT-treated lung metastases derived from retrospective analyses of survival outcomeSamuel M Vorbach, Thomas Seppi, Manuel P Sarcletti, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Tierarztliche Praxis|January 1, 1986
[Clitoral massage as a supporting measure in manipulation of the bovine uterus]J Pointner
Der Urologe. Ausg. A|May 1, 1996
[Laparoscopic spermatic vein ligation]J Pointner, G Janetschek, A Reissigl, et al.
The Prostate|March 1, 1997
Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levelsA Reissigl, H Klocker, J Pointner, et al.
The Prostate|February 1, 1997
Frequency and clinical significance of transition zone cancer in prostate cancer screeningA Reissigl, J Pointner, H Strasser, et al.
Urology|November 1, 1995
Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer: results of a large screening studyA Reissigl, J Pointner, W Horninger, et al.
The Prostate|January 1, 1997
PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donorsA Reissigl, J Pointner, W Horninger, et al.
Urology|December 1, 1996
Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screeningA Reissigl, H Klocker, J Pointner, et al.
Head & Neck|August 8, 2024
A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT-treated lung metastases derived from retrospective analyses of survival outcomeSamuel M Vorbach, Thomas Seppi, Manuel P Sarcletti, et al.
Urology|June 4, 1998
Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancerG P Murphy, G M Kenny, H Ragde, et al.
Cancer|August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigenG P Murphy, R J Barren, S J Erickson, et al.
Pageof 1